- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HR+ Advanced or Metastatic Breast Cancer in New Zealand
Total 678 results
-
BriaCell Therapeutics CorporationRecruitingBreast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Breast Cancer Metastatic | End Stage CancerUnited States
-
Columbia UniversityNational Cancer Institute (NCI); Acetylon Pharmaceuticals IncorporatedCompletedMetastatic Breast Cancer | Breast CarcinomaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...CompletedMetastatic Breast CancerUnited States
-
Monopteros Therapeutics Inc.RecruitingMetastatic Cancer | Advanced Solid Tumor | Advanced Cancer | Solid Tumor, Adult | Refractory CancerUnited States
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.WithdrawnMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)RecruitingMetastatic Breast Cancer | Stage IV Breast Cancer AJCC V7United States
-
Novartis PharmaceuticalsCompletedFirst or Second Line HER2-negative Breast Cancer | Metastatic Disease Without Bone MetastasisUnited States
-
Memorial Sloan Kettering Cancer CenterPfizerActive, not recruitingMetastatic Breast Cancer (MBC)United States
-
Yale UniversityFoundation MedicineCompleted
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Dartmouth-Hitchcock Medical CenterHoffmann-La RocheCompletedMetastatic Breast CancerUnited States
-
Yale UniversityMerck Sharp & Dohme LLCCompletedAdvanced Breast CancerUnited States
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Mayo ClinicNational Cancer Institute (NCI)Enrolling by invitationAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Advanced Triple-Negative Breast CarcinomaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedMetastatic Breast CancerUnited States
-
University of RochesterJohns Hopkins UniversityCompletedMetastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
PfizerCompleted
-
PfizerActive, not recruitingMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterSamus Therapeutics, Inc.CompletedMetastatic Breast CancerUnited States
-
Alaunos TherapeuticsCompletedMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedAdvanced Breast CancerUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedMetastatic Breast CancerUnited States
-
EMD SeronoSanofiCompletedMelanoma | Breast Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Italy, Spain
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareActive, not recruitingMetastatic HER2-Positive Breast CancerUnited States
-
AmgenRoche-GenentechCompletedMetastatic Colorectal Cancer | Metastatic Triple Negative Breast CancerUnited States, Belgium, Spain, Australia, Switzerland, Germany
-
Dartmouth-Hitchcock Medical CenterTerminatedLocally Advanced Breast CancerUnited States
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Weill Medical College of Cornell UniversityUniversity of California, Los AngelesTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Indiana UniversityCompletedMetastatic Breast CancerUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USATerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Locally Advanced Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterRecruitingMetastatic Breast CancerUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Memorial Sloan Kettering Cancer CenterDuke UniversityCompleted
-
Dartmouth-Hitchcock Medical CenterTerminatedMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IV | Solid Carcinoma | HER2-negative Breast Cancer | MEK1 Gene Mutation | MEK2 Gene MutationUnited States
-
Northwell HealthDepYmed Inc.TerminatedMetastatic Breast CancerUnited States
-
AVEO Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States, Germany
-
Astellas Pharma Global Development, Inc.AvailableMetastatic Gastroesophageal Junction (GEJ) Adenocarcinoma | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma Cancer | Metastatic Gastric Adenocarcinoma CancerUnited States, Germany
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic HER2-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Oncolytics BiotechPrECOG, LLC.Active, not recruiting
-
Incyte CorporationTerminatedAdvanced or Metastatic Solid Tumors | FGFR Mutations | FGFR TranslocationsUnited States
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
PTC TherapeuticsUnited States Department of DefenseCompletedMetastatic Breast CancerUnited States